Edited by Roger ColbranThe Na-H exchanger NHE1 contributes to intracellular pH (pH i ) homeostasis in normal cells and the constitutively increased pH i in cancer. NHE1 activity is allosterically regulated by intracellular protons, with greater activity at lower pH i . However, the molecular mechanism for pH-dependent NHE1 activity remains incompletely resolved. We report that an evolutionarily conserved cluster of histidine residues located in the C-terminal cytoplasmic domain between two phosphatidylinositol 4,5-bisphosphate binding sites (PI(4,5)P 2 ) of NHE1 confers pH-dependent PI(4,5)P 2 binding and regulates NHE1 activity. A GST fusion of the wild type C-terminal cytoplasmic domain of NHE1 showed increased maximum PI(4,5)P 2 binding at pH 7.0 compared with pH 7.5. However, pH-sensitive binding is abolished by substitutions of the His-rich cluster to arginine (RXXR3) or alanine (AXXA3), mimicking protonated and neutral histidine residues, respectively, and the RXXR3 mutant had significantly greater PI(4,5)P 2 binding than AXXA3. When expressed in cells, NHE1 activity and pH i were significantly increased with NHE1-RXXR3 and decreased with NHE1-AXXA3 compared with wild type NHE1. Additionally, fibroblasts expressing NHE1-RXXR3 had significantly more contractile actin filaments and focal adhesions compared with fibroblasts expressing wild type NHE1, consistent with increased pH i enabling cytoskeletal remodeling. These data identify a molecular mechanism for pH-sensitive PI(4,5)P 2 binding regulating NHE1 activity and suggest that the evolutionarily conserved cluster of four histidines in the proximal cytoplasmic domain of NHE1 may constitute a proton modifier site. Moreover, a constitutively activated NHE1-RXXR3 mutant is a new tool that will be useful for studying how increased pH i contributes to cell behaviors, most notably the biology of cancer cells.Intracellular pH (pH i ) homeostasis is generally maintained near neutral to compensate for metabolic changes and environmental stresses (1). However, dysregulated pH i is seen in a number of diseases. Most cancers have constitutively increased pH i of ϳ0.4 units, which enables proliferation and metastasis (2-4). Conversely, neurodegenerative disorders, including Parkinson's and Alzheimer's diseases, are associated with constitutively decreased pH i , which is predicted to enable tau and -amyloid aggregation as well as cell death (5, 6). Finely tuned pH i homeostasis is maintained by dynamic changes in ion transporter activity that is sensitive to intracellular proton concentrations. However, the molecular mechanisms that mediate pH sensing by ion transporters remain poorly understood. The ubiquitously expressed Na-H exchanger isoform NHE1 4 contributes to maintaining pH i homeostasis by generating an electroneutral influx of extracellular Na ϩ and efflux of intracellular H ϩ at the plasma membrane. To maintain pH i homeostasis, NHE1 activity increases with acidic pH i and becomes nearly quiescent at neutral pH i . However, NHE1 activity can be increased a...